HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania
- PMID: 27841669
- PMCID: PMC5372774
- DOI: 10.1089/AID.2016.0111
HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania
Abstract
In preparation for vaccine trials, HIV-1 genetic diversity was surveyed between 2002 and 2006 through the Cohort Development study in the form of a retrospective and prospective observational study in and around the town of Mbeya in Tanzania's Southwest Highlands. This study describes the molecular epidemiology of HIV-1 strains obtained from 97 out of 106 incident HIV-1 infections identified in three subpopulations of participants (one rural, two urban) from the Mbeya area. Near full-genome or half-genome sequencing showed a subtype distribution of 40% C, 17% A1, 1% D, and 42% inter-subtype recombinants. Compared to viral subtyping results previously obtained from the retrospective phase of this study, the overall proportion of incident viral strains did not change greatly during the study course, suggesting maturity of the epidemic. A comparison to a current Phase I-II vaccine being tested in Africa shows ∼17% amino acid sequence difference between the gp120 of the vaccine and subtype C incident strains. Phylogenetic and recombinant breakpoint analysis of the incident strains revealed the emergence of CRF41_CD and many unique recombinants, as well as the presence of six local transmission networks most of which were confined to the rural subpopulation. In the context of vaccine cohort selection, these results suggest distinct infection transmission dynamics within these three geographically close subpopulations. The diversity and genetic sequences of the HIV-1 strains obtained during this study will greatly contribute to the planning, immunogen selection, and analysis of vaccine-induced immune responses observed during HIV-1 vaccine trials in Tanzania and neighboring countries.
Keywords: HIV genetics; HIV transmission; epidemiology; phylogenetics; vaccines.
Conflict of interest statement
The material has been reviewed by the Walter Reed Army Institute of Research and there is no objection to its presentation and/or publication. The Walter Reed Army Institute of Research Institutional Research Board human use protocol #W923 (RV143). “Infectious Disease Surveillance (HIV, TB, and Malaria) and CODE Among Urban and Rural Adults in Mbeya Municipality, Tanzania,” is funded through the U.S. Military HIV Research Program (the Walter Reed Army Institute of Research and the Henry M. Jackson Foundation for the Advancement of Military Medicine). This work was supported by cooperative agreements (DAMD17-98-2-7007, W81XWH-04-2-0005, W81XWH-07-2-0067, and W81XWH-11-2-0174) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and the U.S. Department of Defense (DOD). No competing financial interests exist.
Figures




References
-
- UNAIDS: United Republic of Tanzania—HIV and AIDS estimates. www.unaids.org/en/regionscountries/countries/unitedrepublicoftanzania (2015) accessed September23, 2015
-
- Tanzania Commission for AIDS (TACAIDS) NBoSN, and ORC Macro. Tanzania HIV/AIDS Indicator Survey 2003–04. Calverton, Maryland, TACAIDS, NBS, and ORC Macro, 2005
-
- Tanzania Commission for AIDS (TACAIDS) ZACZ, National Bureau of Statistics (NBS), Office of the Chief Government Statistician (OCGS), and Macro International Inc. Tanzania HIV/AIDS and Malaria Indicator Survey 2007–08. Dar es Salaam, Tanzania, TACAIDS, ZAC, NBS, OCGS, and Macro International, Inc., 2008
-
- Tanzania Commission for AIDS (TACAIDS) ZACZ, National Bureau of Statistics (NBS), Office of the Chief Government Statistician (OCGS), and ICF International. Tanzania HIV/AIDS and Malaria Indicator Survey 2011–12. Dar es Salaam, Tanzania, TACAIDS, ZAC, NBS, OCGS, and ICF International, 2013
-
- Arroyo MA, Hoelscher M, Sateren W, et al. : HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania. AIDS 2005;19:1517–1524 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases